Anzeige
Mehr »
Login
Donnerstag, 02.07.2020 Börsentäglich über 12.000 News von 632 internationalen Medien
Mega-Treffer! Diese Silber-Rakete startet voll durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1J440 ISIN: GB00B89J2419 Ticker-Symbol: 78C 
Frankfurt
02.07.20
09:16 Uhr
8,900 Euro
+0,090
+1,02 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
CLINIGEN GROUP PLC Chart 1 Jahr
5-Tage-Chart
CLINIGEN GROUP PLC 5-Tage-Chart
RealtimeGeldBriefZeit
8,8659,19011:30

Aktuelle News zur CLINIGEN Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiClinigen Group plc: Total Voting Rights-
15.06.Clinigen circled by private equity firm for takeover bid, say reports-
CLINIGEN Aktie jetzt für 0€ handeln
14.06.Sunday newspaper round-up: Two meters, Rolls Royce, Clinigen65
10.06.Clinigen Group plc: Issue of Equity-
05.06.Clinigen Group plc: Director/PDMR Shareholding1
28.05.Clinigen climbs on encouraging Iovance melanoma data12
28.05.Broker Forecast - Liberum Capital issues a broker note on Clinigen Group1
26.05.Clinigen Chair Leaves Audit Committee After Shareholder Engagement1
26.05.BRIEF-Clinigen Group Says Peter Allen Relinquished Position As Member Of A Committee-
26.05.Clinigen chairman relinquishes audit committee role-
26.05.Clinigen Group plc: Update on 2019 AGM resolution vote-
14.05.Xeris Pharmaceuticals Signs Exclusive Agreement With Clinigen to Supply and Distribute Gvoke Outside the U.S on a Named Patient Basis747Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable and infusible...
► Artikel lesen
04.05.Clinigen: IL-2 Plays Role in Emerging TIL Therapies135PROLEUKIN (aldesleukin) the first and only approved recombinant IL-2 Clinigen Group plc (AIM: CLIN, 'Clinigen' or the 'Group'), the global pharmaceutical and services company acknowledges the...
► Artikel lesen
01.05.Clinigen Group plc: Appointment of Nominated Adviser and Joint Broker-
17.04.Clinigen looks to keep world's pharmaceutical supplies well-stocked1
17.04.Clinigen target price hiked by Liberum as broker predicts 35% share price upside 'in the next six months'-
17.04.Broker Forecast - Liberum Capital issues a broker note on Clinigen Group-
16.04.Proactive news snapshot: Clinigen, Europa Metals, Collagen Solutions, Base Resources …1
16.04.Clinigen Says Annual Trading In Line; Signs Erwinase License Agreement-
16.04.Clinigen signs distribution agreement with Porton Biopharma; says performance remains in line with expectations-
Seite:  Weiter >>
54 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1